UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$1.21B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$855M |
| 3 |
Microsoft
MSFT
|
+$810M |
| 4 |
Advanced Micro Devices
AMD
|
+$805M |
| 5 |
Boeing
BA
|
+$739M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$561M |
| 2 |
Amneal Pharmaceuticals
AMRX
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$161M |
| 4 |
Unity
U
|
+$158M |
| 5 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.49% |
| 2 | Financials | 9.06% |
| 3 | Consumer Discretionary | 7.01% |
| 4 | Healthcare | 6.25% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4826
National CineMedia
NCMI
$378M
| $1.77M | ﹤0.01% |
266,165
+225,754
| +559% | +$1.55M |
|
4827
PLDT
PHI
$4.33B
| $1.76M | ﹤0.01% |
79,617
+71,847
| +925% | +$1.71M |
|
4828
Vir Biotechnology
VIR
$1.49B
| $1.76M | ﹤0.01% |
240,113
-143,075
| -37% | -$1.13M |
|
4829
Navient
NAVI
$853M
| $1.76M | ﹤0.01% |
132,503
+82,595
| +165% | +$1.24M |
|
4830
ADC Therapeutics
ADCT
$144M
| $1.76M | ﹤0.01% |
884,518
+844,743
| +2,124% | +$2.21M |
|
|
UROY
4831
Uranium Royalty Corp
UROY
$1.58B
| $1.76M | ﹤0.01% |
802,359
+341,316
| +74% | +$877K |
|
|
CIM
4832
CALL
Chimera Investment
CIM
$1B
| $1.76M | ﹤0.01% |
125,500
| – | – |
|
4833
Freedom Holding
FRHC
$9.49B
| $1.76M | ﹤0.01% |
13,440
+10,705
| +391% | +$1.23M |
|
4834
iShares Emerging Markets Equity Factor ETF
EMGF
$1.87B
| $1.76M | ﹤0.01% |
38,831
+2,878
| +8% | +$138K |
|
|
FCT
4835
First Trust Senior Floating Rate Income Fund II
FCT
$251M
| $1.75M | ﹤0.01% |
169,503
-27,008
| -14% | -$280K |
|
4836
STAAR Surgical
STAA
$1.21B
| $1.75M | ﹤0.01% |
72,152
+53,109
| +279% | +$1.52M |
|
4837
TriCo Bancshares
TCBK
$1.83B
| $1.75M | ﹤0.01% |
40,097
+11,681
| +41% | +$532K |
|
4838
CALL
Bath & Body Works
BBWI
$4.1B
| $1.74M | ﹤0.01% |
45,000
+30,000
| +200% | +$1M |
|
4839
TFS Financial
TFSL
$4.93B
| $1.74M | ﹤0.01% |
138,885
+91,949
| +196% | +$1.22M |
|
4840
Pagaya Technologies
PGY
$1.78B
| $1.74M | ﹤0.01% |
187,703
+130,560
| +228% | +$1.38M |
|
4841
Pacer Industrial Real Estate ETF
INDS
$117M
| $1.74M | ﹤0.01% |
49,396
-68,752
| -58% | -$2.67M |
|
4842
Northeast Bank
NBN
$1.14B
| $1.74M | ﹤0.01% |
18,990
+15,206
| +402% | +$1.4M |
|
|
AMPS
4843
DELISTED
Altus Power
AMPS
| $1.74M | ﹤0.01% |
427,941
+378,038
| +758% | +$1.38M |
|
4844
Instil Bio
TIL
$50.3M
| $1.74M | ﹤0.01% |
91,086
+90,955
| +69,431% | +$2.77M |
|
4845
Heartland Express
HTLD
$956M
| $1.74M | ﹤0.01% |
154,964
+27,280
| +21% | +$321K |
|
4846
abrdn Physical Palladium Shares ETF
PALL
$681M
| $1.74M | ﹤0.01% |
104,025
+30,745
| +42% | +$570K |
|
|
AAT
4847
American Assets Trust
AAT
$1.4B
| $1.74M | ﹤0.01% |
66,170
+38,479
| +139% | +$1.05M |
|
4848
CALL
iShares Global Clean Energy ETF
ICLN
$2.1B
| $1.74M | ﹤0.01% |
152,500
+152,400
| +152,400% | +$1.93M |
|
4849
CALL
eBay
EBAY
$49.8B
| $1.73M | ﹤0.01% |
28,000
| – | – |
|
4850
Bally's
BALY
$658M
| $1.73M | ﹤0.01% |
96,869
-85,971
| -47% | -$1.52M |
|
Similar funds
UBS Group's Q4 2024 Portfolio in Review
As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.
- UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
- UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
- UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
- UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
- UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
- UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.